ID   STOM_HUMAN              Reviewed;         288 AA.
AC   P27105; B1AM77; Q14087; Q15609; Q5VX96; Q96FK4;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   18-JUN-2025, entry version 224.
DE   RecName: Full=Stomatin {ECO:0000312|HGNC:HGNC:3383};
DE   AltName: Full=Erythrocyte band 7 integral membrane protein {ECO:0000303|PubMed:1883838};
DE   AltName: Full=Erythrocyte membrane protein band 7.2 {ECO:0000312|HGNC:HGNC:3383};
DE   AltName: Full=Protein 7.2b {ECO:0000303|PubMed:8825639};
GN   Name=STOM {ECO:0000312|HGNC:HGNC:3383};
GN   Synonyms=BND7 {ECO:0000312|HGNC:HGNC:3383}, EPB72
GN   {ECO:0000303|PubMed:8825639};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=1883838; DOI=10.1016/0167-4781(91)90047-p;
RA   Hiebl-Dirschmied C.M., Entler B., Glotzmann C., Maurer-Fogy I.,
RA   Stratowa C., Prohaska R.;
RT   "Cloning and nucleotide sequence of cDNA encoding human erythrocyte band 7
RT   integral membrane protein.";
RL   Biochim. Biophys. Acta 1090:123-124(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 187-232, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Bone marrow;
RX   PubMed=1547348;
RA   Stewart G.W., Hepworth-Jones B.E., Keen J.N., Dash B.C.J., Argent A.C.,
RA   Casimir C.M.;
RT   "Isolation of cDNA coding for an ubiquitous membrane protein deficient in
RT   high Na+, low K+ stomatocytic erythrocytes.";
RL   Blood 79:1593-1601(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8825639; DOI=10.1006/geno.1995.1273;
RA   Unfried I., Entler B., Prohaska R.;
RT   "The organization of the gene (EPB72) encoding the human erythrocyte band 7
RT   integral membrane protein (protein 7.2b).";
RL   Genomics 30:521-528(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7592848; DOI=10.1074/jbc.270.44.26358;
RA   Gallagher P.G., Forget B.G.;
RT   "Structure, organization, and expression of the human band 7.2b gene, a
RT   candidate gene for hereditary hydrocytosis.";
RL   J. Biol. Chem. 270:26358-26363(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Eye, and Hypothalamus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 5-25, AND PHOSPHORYLATION AT SER-10.
RX   PubMed=8373790; DOI=10.1016/0005-2736(93)90098-k;
RA   Salzer U., Ahorn H., Prohaska R.;
RT   "Identification of the phosphorylation site on human erythrocyte band 7
RT   integral membrane protein: implications for a monotopic protein
RT   structure.";
RL   Biochim. Biophys. Acta 1151:149-152(1993).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9243190;
RA   Snyers L., Thines-Sempoux D., Prohaska R.;
RT   "Colocalization of stomatin (band 7.2b) and actin microfilaments in UAC
RT   epithelial cells.";
RL   Eur. J. Cell Biol. 73:281-285(1997).
RN   [10]
RP   INTERACTION WITH LANCL1.
RC   TISSUE=Bone marrow, Erythrocyte, and Fetal brain;
RX   PubMed=9512664; DOI=10.1016/s0167-4781(97)00178-4;
RA   Mayer H., Salzer U., Breuss J., Ziegler S., Marchler-Bauer A., Prohaska R.;
RT   "Isolation, molecular characterization, and tissue-specific expression of a
RT   novel putative G protein-coupled receptor.";
RL   Biochim. Biophys. Acta 1395:301-308(1998).
RN   [11]
RP   SUBUNIT.
RX   PubMed=9642292; DOI=10.1074/jbc.273.27.17221;
RA   Snyers L., Umlauf E., Prohaska R.;
RT   "Oligomeric nature of the integral membrane protein stomatin.";
RL   J. Biol. Chem. 273:17221-17226(1998).
RN   [12]
RP   PALMITOYLATION AT CYS-30 AND CYS-87.
RX   PubMed=10338112; DOI=10.1016/s0014-5793(99)00417-2;
RA   Snyers L., Umlauf E., Prohaska R.;
RT   "Cysteine 29 is the major palmitoylation site on stomatin.";
RL   FEBS Lett. 449:101-104(1999).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12130500; DOI=10.1182/blood.v100.3.897;
RA   Mairhofer M., Steiner M., Mosgoeller W., Prohaska R., Salzer U.;
RT   "Stomatin is a major lipid-raft component of platelet alpha granules.";
RL   Blood 100:897-904(2002).
RN   [14]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=12643545; DOI=10.1021/pr025562r;
RA   Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K., Valencia J.,
RA   Muller J., Vieira W.D., Watabe H., Shabanowitz J., Hearing V.J., Hunt D.F.,
RA   Appella E.;
RT   "Proteomic analysis of early melanosomes: identification of novel
RT   melanosomal proteins.";
RL   J. Proteome Res. 2:69-79(2003).
RN   [15]
RP   MUTAGENESIS OF THR-182; TRP-185; TYR-252 AND 263-LYS--LEU-276.
RX   PubMed=16766530; DOI=10.1074/jbc.m513720200;
RA   Umlauf E., Mairhofer M., Prohaska R.;
RT   "Characterization of the stomatin domain involved in homo-oligomerization
RT   and lipid raft association.";
RL   J. Biol. Chem. 281:23349-23356(2006).
RN   [16]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [18]
RP   INTERACTION WITH STOML1.
RX   PubMed=19696025; DOI=10.1074/jbc.m109.014993;
RA   Mairhofer M., Steiner M., Salzer U., Prohaska R.;
RT   "Stomatin-like protein-1 interacts with stomatin and is targeted to late
RT   endosomes.";
RL   J. Biol. Chem. 284:29218-29229(2009).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INTERACTION WITH SLC2A1 AND
RP   SLC4A1, AND SUBUNIT.
RX   PubMed=23219802; DOI=10.1016/j.bbamem.2012.11.030;
RA   Rungaldier S., Oberwagner W., Salzer U., Csaszar E., Prohaska R.;
RT   "Stomatin interacts with GLUT1/SLC2A1, band 3/SLC4A1, and aquaporin-1 in
RT   human erythrocyte membrane domains.";
RL   Biochim. Biophys. Acta 1828:956-966(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10 AND SER-18, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [24]
RP   INTERACTION WITH SLC4A1.
RX   PubMed=28387307; DOI=10.1038/srep46170;
RA   Genetet S., Desrames A., Chouali Y., Ripoche P., Lopez C.,
RA   Mouro-Chanteloup I.;
RT   "Stomatin modulates the activity of the Anion Exchanger 1 (AE1, SLC4A1).";
RL   Sci. Rep. 7:46170-46170(2017).
CC   -!- FUNCTION: Regulates ion channel activity and transmembrane ion
CC       transport. Regulates ASIC2 and ASIC3 channel activity.
CC   -!- SUBUNIT: Homodimer and higher order homooligomer (PubMed:9642292). The
CC       homodimer is banana-shaped (PubMed:9642292). Interacts with ASIC1,
CC       ASIC2 and ASIC3 (By similarity). Interacts with LANCL1
CC       (PubMed:9512664). Interacts with SLC2A1 (PubMed:23219802). Interacts
CC       with SLC4A1; this interaction positively regulates SLC4A1 activity
CC       (PubMed:23219802, PubMed:28387307). Identified in large complexes with
CC       SLC40A1, SLC14A1, SLC29A1 and AQP1 (PubMed:23219802). Interacts with
CC       STOML1; may redistribute STOM from the plasma membrane to late
CC       endosomes (PubMed:19696025). {ECO:0000250|UniProtKB:P54116,
CC       ECO:0000269|PubMed:19696025, ECO:0000269|PubMed:23219802,
CC       ECO:0000269|PubMed:28387307, ECO:0000269|PubMed:9512664,
CC       ECO:0000269|PubMed:9642292}.
CC   -!- INTERACTION:
CC       P27105; Q9NVV5-2: AIG1; NbExp=3; IntAct=EBI-1211440, EBI-11957045;
CC       P27105; P02652: APOA2; NbExp=3; IntAct=EBI-1211440, EBI-1171525;
CC       P27105; P54709: ATP1B3; NbExp=3; IntAct=EBI-1211440, EBI-1054481;
CC       P27105; Q99437: ATP6V0B; NbExp=3; IntAct=EBI-1211440, EBI-3904417;
CC       P27105; P27449: ATP6V0C; NbExp=3; IntAct=EBI-1211440, EBI-721179;
CC       P27105; Q92843: BCL2L2; NbExp=3; IntAct=EBI-1211440, EBI-707714;
CC       P27105; Q12981: BNIP1; NbExp=3; IntAct=EBI-1211440, EBI-4402847;
CC       P27105; P06681: C2; NbExp=3; IntAct=EBI-1211440, EBI-2835920;
CC       P27105; Q9BXR6: CFHR5; NbExp=3; IntAct=EBI-1211440, EBI-11579371;
CC       P27105; O43916: CHST1; NbExp=3; IntAct=EBI-1211440, EBI-748017;
CC       P27105; Q8N6F1-2: CLDN19; NbExp=3; IntAct=EBI-1211440, EBI-12256978;
CC       P27105; A0PK11: CLRN2; NbExp=3; IntAct=EBI-1211440, EBI-12813623;
CC       P27105; Q96DZ9-2: CMTM5; NbExp=3; IntAct=EBI-1211440, EBI-11522780;
CC       P27105; Q8TBE1: CNIH3; NbExp=3; IntAct=EBI-1211440, EBI-12208021;
CC       P27105; Q4LDR2: CTXN3; NbExp=3; IntAct=EBI-1211440, EBI-12019274;
CC       P27105; O43169: CYB5B; NbExp=3; IntAct=EBI-1211440, EBI-1058710;
CC       P27105; P00387: CYB5R3; NbExp=4; IntAct=EBI-1211440, EBI-1046040;
CC       P27105; Q9Y4D2: DAGLA; NbExp=3; IntAct=EBI-1211440, EBI-12808806;
CC       P27105; Q92997: DVL3; NbExp=3; IntAct=EBI-1211440, EBI-739789;
CC       P27105; P54849: EMP1; NbExp=3; IntAct=EBI-1211440, EBI-4319440;
CC       P27105; Q9UKR5: ERG28; NbExp=3; IntAct=EBI-1211440, EBI-711490;
CC       P27105; Q96IV6: FAXDC2; NbExp=3; IntAct=EBI-1211440, EBI-12142299;
CC       P27105; Q9BWH2: FUNDC2; NbExp=3; IntAct=EBI-1211440, EBI-714482;
CC       P27105; Q8WWP7: GIMAP1; NbExp=3; IntAct=EBI-1211440, EBI-11991950;
CC       P27105; Q96F15: GIMAP5; NbExp=3; IntAct=EBI-1211440, EBI-6166686;
CC       P27105; O00155: GPR25; NbExp=3; IntAct=EBI-1211440, EBI-10178951;
CC       P27105; O60883: GPR37L1; NbExp=3; IntAct=EBI-1211440, EBI-2927498;
CC       P27105; Q14416: GRM2; NbExp=3; IntAct=EBI-1211440, EBI-10232876;
CC       P27105; P30519: HMOX2; NbExp=3; IntAct=EBI-1211440, EBI-712096;
CC       P27105; O00180: KCNK1; NbExp=3; IntAct=EBI-1211440, EBI-3914675;
CC       P27105; Q86UP2-3: KTN1; NbExp=3; IntAct=EBI-1211440, EBI-12007212;
CC       P27105; Q9UIQ6-2: LNPEP; NbExp=3; IntAct=EBI-1211440, EBI-12133176;
CC       P27105; A0A0C4DFN3: MGLL; NbExp=3; IntAct=EBI-1211440, EBI-12866138;
CC       P27105; P50281: MMP14; NbExp=3; IntAct=EBI-1211440, EBI-992788;
CC       P27105; Q16617: NKG7; NbExp=5; IntAct=EBI-1211440, EBI-3919611;
CC       P27105; Q9P0S3: ORMDL1; NbExp=3; IntAct=EBI-1211440, EBI-1054848;
CC       P27105; I3L0A0: PEDS1-UBE2V1; NbExp=3; IntAct=EBI-1211440, EBI-12213001;
CC       P27105; Q9UBM1-2: PEMT; NbExp=3; IntAct=EBI-1211440, EBI-17513590;
CC       P27105; P0DJD7: PGA4; NbExp=3; IntAct=EBI-1211440, EBI-12957629;
CC       P27105; Q01453: PMP22; NbExp=3; IntAct=EBI-1211440, EBI-2845982;
CC       P27105; Q13635-3: PTCH1; NbExp=3; IntAct=EBI-1211440, EBI-14199621;
CC       P27105; Q9NS64: RPRM; NbExp=3; IntAct=EBI-1211440, EBI-1052363;
CC       P27105; Q5QGT7: RTP2; NbExp=3; IntAct=EBI-1211440, EBI-10244780;
CC       P27105; O00767: SCD; NbExp=3; IntAct=EBI-1211440, EBI-2684237;
CC       P27105; Q9Y6D0: SELENOK; NbExp=3; IntAct=EBI-1211440, EBI-9679163;
CC       P27105; Q8N6R1: SERP2; NbExp=3; IntAct=EBI-1211440, EBI-749270;
CC       P27105; Q8WV19: SFT2D1; NbExp=3; IntAct=EBI-1211440, EBI-2854842;
CC       P27105; O95562: SFT2D2; NbExp=3; IntAct=EBI-1211440, EBI-4402330;
CC       P27105; Q9H9B4: SFXN1; NbExp=3; IntAct=EBI-1211440, EBI-355861;
CC       P27105; Q8TD22: SFXN5; NbExp=3; IntAct=EBI-1211440, EBI-17274136;
CC       P27105; Q969S0: SLC35B4; NbExp=3; IntAct=EBI-1211440, EBI-10281213;
CC       P27105; P02730: SLC4A1; NbExp=14; IntAct=EBI-1211440, EBI-7576138;
CC       P27105; Q9NRQ5: SMCO4; NbExp=3; IntAct=EBI-1211440, EBI-8640191;
CC       P27105; P27105: STOM; NbExp=3; IntAct=EBI-1211440, EBI-1211440;
CC       P27105; Q9UBI4: STOML1; NbExp=4; IntAct=EBI-1211440, EBI-2681162;
CC       P27105; O43752: STX6; NbExp=3; IntAct=EBI-1211440, EBI-2695795;
CC       P27105; Q9NZ01: TECR; NbExp=3; IntAct=EBI-1211440, EBI-2877718;
CC       P27105; Q9C0I4: THSD7B; NbExp=3; IntAct=EBI-1211440, EBI-311394;
CC       P27105; Q9BVC6: TMEM109; NbExp=3; IntAct=EBI-1211440, EBI-1057733;
CC       P27105; A0PK00: TMEM120B; NbExp=3; IntAct=EBI-1211440, EBI-10171534;
CC       P27105; Q9NV12: TMEM140; NbExp=3; IntAct=EBI-1211440, EBI-2844246;
CC       P27105; Q9NUH8: TMEM14B; NbExp=3; IntAct=EBI-1211440, EBI-8638294;
CC       P27105; Q969S6: TMEM203; NbExp=3; IntAct=EBI-1211440, EBI-12274070;
CC       P27105; Q9BTX3: TMEM208; NbExp=3; IntAct=EBI-1211440, EBI-12876824;
CC       P27105; Q8TBM7: TMEM254; NbExp=3; IntAct=EBI-1211440, EBI-11956809;
CC       P27105; Q9H2L4: TMEM60; NbExp=3; IntAct=EBI-1211440, EBI-2852148;
CC       P27105; Q8N661: TMEM86B; NbExp=3; IntAct=EBI-1211440, EBI-2548832;
CC       P27105; Q9Y2Y6: TMEM98; NbExp=3; IntAct=EBI-1211440, EBI-7333781;
CC       P27105; P42167: TMPO; NbExp=3; IntAct=EBI-1211440, EBI-455283;
CC       P27105; P01375: TNF; NbExp=3; IntAct=EBI-1211440, EBI-359977;
CC       P27105; O14798: TNFRSF10C; NbExp=3; IntAct=EBI-1211440, EBI-717441;
CC       P27105; Q5TGU0: TSPO2; NbExp=3; IntAct=EBI-1211440, EBI-12195249;
CC       P27105; Q5BVD1: TTMP; NbExp=3; IntAct=EBI-1211440, EBI-10243654;
CC       P27105; O75379: VAMP4; NbExp=3; IntAct=EBI-1211440, EBI-744953;
CC       P27105; Q14508: WFDC2; NbExp=3; IntAct=EBI-1211440, EBI-723529;
CC       P27105; Q96EC8: YIPF6; NbExp=3; IntAct=EBI-1211440, EBI-751210;
CC       P27105; PRO_0000037552 [Q9WMX2]; Xeno; NbExp=3; IntAct=EBI-1211440, EBI-9005440;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9243190};
CC       Peripheral membrane protein {ECO:0000269|PubMed:9243190}; Cytoplasmic
CC       side {ECO:0000269|PubMed:9243190}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:9243190}. Cell membrane
CC       {ECO:0000269|PubMed:12130500}; Lipid-anchor
CC       {ECO:0000269|PubMed:12130500}; Cytoplasmic side
CC       {ECO:0000269|PubMed:12130500}. Membrane raft
CC       {ECO:0000269|PubMed:12130500, ECO:0000269|PubMed:23219802}. Melanosome
CC       {ECO:0000269|PubMed:12643545, ECO:0000269|PubMed:17081065}. Cytoplasmic
CC       vesicle {ECO:0000250|UniProtKB:P54116}. Note=Localizes to juxtanuclear
CC       structure probably derived from the Golgi apparatus (PubMed:9243190).
CC       Colocalizes with cortical actin microfilaments at small plasma membrane
CC       protrusions (PubMed:9243190). Associates with alpha-granular lipid
CC       rafts (PubMed:12130500). Translocates from the alpha-granular lipid
CC       rafts to the cell membrane on thrombin activation and selectively
CC       enriched in released microvesicles (PubMed:12130500). Identified by
CC       mass spectrometry in melanosome fractions from stage I to stage IV
CC       (PubMed:12643545). {ECO:0000269|PubMed:12130500,
CC       ECO:0000269|PubMed:12643545, ECO:0000269|PubMed:9243190}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P27105-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P27105-2; Sequence=VSP_044669;
CC   -!- TISSUE SPECIFICITY: Detected in erythrocytes (at protein level). Widely
CC       expressed. {ECO:0000269|PubMed:1547348, ECO:0000269|PubMed:23219802}.
CC   -!- SIMILARITY: Belongs to the band 7/mec-2 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X60067; CAA42671.1; -; mRNA.
DR   EMBL; M81635; AAA58432.1; -; mRNA.
DR   EMBL; X85116; CAA59436.1; -; Genomic_DNA.
DR   EMBL; X85117; CAA59436.1; JOINED; Genomic_DNA.
DR   EMBL; U33931; AAC50296.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; U33925; AAC50296.1; JOINED; Genomic_DNA.
DR   EMBL; U33926; AAC50296.1; JOINED; Genomic_DNA.
DR   EMBL; U33927; AAC50296.1; JOINED; Genomic_DNA.
DR   EMBL; U33928; AAC50296.1; JOINED; Genomic_DNA.
DR   EMBL; U33929; AAC50296.1; JOINED; Genomic_DNA.
DR   EMBL; U33930; AAC50296.1; JOINED; Genomic_DNA.
DR   EMBL; CR542100; CAG46897.1; -; mRNA.
DR   EMBL; AL359644; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL161784; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC010703; AAH10703.1; -; mRNA.
DR   EMBL; BI603242; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS6830.1; -. [P27105-1]
DR   CCDS; CCDS6831.1; -. [P27105-2]
DR   PIR; S17659; S17659.
DR   RefSeq; NP_004090.4; NM_004099.5. [P27105-1]
DR   RefSeq; NP_937837.1; NM_198194.3. [P27105-2]
DR   PDB; 7WH3; NMR; -; A=94-202.
DR   PDBsum; 7WH3; -.
DR   AlphaFoldDB; P27105; -.
DR   BMRB; P27105; -.
DR   SMR; P27105; -.
DR   BioGRID; 108354; 374.
DR   CORUM; P27105; -.
DR   FunCoup; P27105; 669.
DR   IntAct; P27105; 209.
DR   MINT; P27105; -.
DR   STRING; 9606.ENSP00000286713; -.
DR   TCDB; 8.A.21.1.1; the stomatin/podocin/band 7/nephrosis,2/spfh (stomatin) family.
DR   GlyGen; P27105; 5 sites, 3 N-linked glycans (4 sites), 1 O-linked glycan (1 site).
DR   iPTMnet; P27105; -.
DR   MetOSite; P27105; -.
DR   PhosphoSitePlus; P27105; -.
DR   SwissPalm; P27105; -.
DR   BioMuta; STOM; -.
DR   DMDM; 114823; -.
DR   CPTAC; CPTAC-276; -.
DR   CPTAC; CPTAC-277; -.
DR   jPOST; P27105; -.
DR   MassIVE; P27105; -.
DR   PaxDb; 9606-ENSP00000286713; -.
DR   PeptideAtlas; P27105; -.
DR   PRIDE; P27105; -.
DR   ProteomicsDB; 3187; -.
DR   ProteomicsDB; 54374; -. [P27105-1]
DR   Pumba; P27105; -.
DR   Antibodypedia; 2509; 262 antibodies from 33 providers.
DR   DNASU; 2040; -.
DR   Ensembl; ENST00000286713.7; ENSP00000286713.2; ENSG00000148175.13. [P27105-1]
DR   Ensembl; ENST00000347359.3; ENSP00000339607.2; ENSG00000148175.13. [P27105-2]
DR   GeneID; 2040; -.
DR   KEGG; hsa:2040; -.
DR   MANE-Select; ENST00000286713.7; ENSP00000286713.2; NM_004099.6; NP_004090.4.
DR   UCSC; uc004blh.5; human. [P27105-1]
DR   AGR; HGNC:3383; -.
DR   CTD; 2040; -.
DR   DisGeNET; 2040; -.
DR   GeneCards; STOM; -.
DR   HGNC; HGNC:3383; STOM.
DR   HPA; ENSG00000148175; Low tissue specificity.
DR   MIM; 133090; gene.
DR   OpenTargets; ENSG00000148175; -.
DR   VEuPathDB; HostDB:ENSG00000148175; -.
DR   eggNOG; KOG2621; Eukaryota.
DR   GeneTree; ENSGT01030000234614; -.
DR   HOGENOM; CLU_024949_3_0_1; -.
DR   InParanoid; P27105; -.
DR   OMA; MFQVTDP; -.
DR   OrthoDB; 2105077at2759; -.
DR   PAN-GO; P27105; 1 GO annotation based on evolutionary models.
DR   PhylomeDB; P27105; -.
DR   PathwayCommons; P27105; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-8980692; RHOA GTPase cycle.
DR   Reactome; R-HSA-9013026; RHOB GTPase cycle.
DR   Reactome; R-HSA-9013106; RHOC GTPase cycle.
DR   Reactome; R-HSA-9013148; CDC42 GTPase cycle.
DR   Reactome; R-HSA-9013406; RHOQ GTPase cycle.
DR   Reactome; R-HSA-9013407; RHOH GTPase cycle.
DR   Reactome; R-HSA-9013409; RHOJ GTPase cycle.
DR   SignaLink; P27105; -.
DR   SIGNOR; P27105; -.
DR   BioGRID-ORCS; 2040; 13 hits in 1159 CRISPR screens.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; STOM; human.
DR   GeneWiki; Stomatin; -.
DR   GenomeRNAi; 2040; -.
DR   Pharos; P27105; Tbio.
DR   PRO; PR:P27105; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; P27105; protein.
DR   Bgee; ENSG00000148175; Expressed in visceral pleura and 218 other cell types or tissues.
DR   ExpressionAtlas; P27105; baseline and differential.
DR   GO; GO:0035577; C:azurophil granule membrane; TAS:Reactome.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:AgBase.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:AgBase.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0008200; F:ion channel inhibitor activity; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0070063; F:RNA polymerase binding; IPI:AgBase.
DR   GO; GO:0044829; P:positive regulation by host of viral genome replication; IEA:Ensembl.
DR   GO; GO:0090314; P:positive regulation of protein targeting to membrane; IEA:Ensembl.
DR   GO; GO:0048524; P:positive regulation of viral process; IEA:Ensembl.
DR   GO; GO:0034765; P:regulation of monoatomic ion transmembrane transport; IEA:Ensembl.
DR   CDD; cd03403; SPFH_stomatin; 1.
DR   FunFam; 3.30.479.30:FF:000002; band 7 protein AGAP004871; 1.
DR   Gene3D; 6.10.250.2090; -; 1.
DR   Gene3D; 3.30.479.30; Band 7 domain; 1.
DR   InterPro; IPR043202; Band-7_stomatin-like.
DR   InterPro; IPR001107; Band_7.
DR   InterPro; IPR036013; Band_7/SPFH_dom_sf.
DR   InterPro; IPR018080; Band_7/stomatin-like_CS.
DR   InterPro; IPR001972; Stomatin_HflK_fam.
DR   PANTHER; PTHR10264; BAND 7 PROTEIN-RELATED; 1.
DR   PANTHER; PTHR10264:SF115; STOMATIN; 1.
DR   Pfam; PF01145; Band_7; 1.
DR   PRINTS; PR00721; STOMATIN.
DR   SMART; SM00244; PHB; 1.
DR   SUPFAM; SSF117892; Band 7/SPFH domain; 1.
DR   PROSITE; PS01270; BAND_7; 1.
DR   neXtProt; NX_P27105; -.
DR   PharmGKB; PA27816; -.
DR   TreeFam; TF105750; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Cytoplasm;
KW   Cytoplasmic vesicle; Cytoskeleton; Direct protein sequencing; Lipoprotein;
KW   Membrane; Palmitate; Phosphoprotein; Proteomics identification;
KW   Reference proteome.
FT   CHAIN           1..288
FT                   /note="Stomatin"
FT                   /id="PRO_0000094027"
FT   TOPO_DOM        1..25
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        26..54
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        55..288
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          1..22
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          265..273
FT                   /note="Required for homooligomerization"
FT   REGION          267..269
FT                   /note="Required for lipid raft association"
FT   REGION          273..287
FT                   /note="Interaction with LANCL1"
FT                   /evidence="ECO:0000269|PubMed:9512664"
FT   MOD_RES         10
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:8373790,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         18
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         161
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P54116"
FT   MOD_RES         244
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:24275569"
FT   LIPID           30
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:10338112"
FT   LIPID           87
FT                   /note="S-palmitoyl cysteine; partial"
FT                   /evidence="ECO:0000269|PubMed:10338112"
FT   VAR_SEQ         55..219
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_044669"
FT   MUTAGEN         182
FT                   /note="T->A: No effect on oligomerization."
FT                   /evidence="ECO:0000269|PubMed:16766530"
FT   MUTAGEN         185
FT                   /note="W->A: Complete loss of oligomerization."
FT                   /evidence="ECO:0000269|PubMed:16766530"
FT   MUTAGEN         252
FT                   /note="Y->A: Complete loss of oligomerization."
FT                   /evidence="ECO:0000269|PubMed:16766530"
FT   MUTAGEN         263
FT                   /note="K->A: Reduced oligomerization and lipid raft
FT                   association."
FT   MUTAGEN         264
FT                   /note="N->A: Reduced oligomerization and lipid raft
FT                   association."
FT   MUTAGEN         265
FT                   /note="S->A: Oligomerization reduced to 18%. Reduced lipid
FT                   raft association."
FT   MUTAGEN         266
FT                   /note="T->A: Complete loss of oligomerization. Reduced
FT                   lipid raft association."
FT   MUTAGEN         267
FT                   /note="I->A: Complete loss of oligomerization and lipid
FT                   raft association."
FT   MUTAGEN         268
FT                   /note="V->A: Complete loss of oligomerization and lipid
FT                   raft association."
FT   MUTAGEN         269
FT                   /note="F->A: Complete loss of oligomerization and lipid
FT                   raft association."
FT   MUTAGEN         270
FT                   /note="P->A: Complete loss of oligomerization. No effect on
FT                   lipid raft association."
FT   MUTAGEN         271
FT                   /note="L->A: Complete loss of oligomerization. Reduced
FT                   lipid raft association."
FT   MUTAGEN         272
FT                   /note="P->A: Oligomerization reduced to 18%. Reduced lipid
FT                   raft association."
FT   MUTAGEN         273
FT                   /note="I->A: Complete loss of oligomerization. Reduced
FT                   lipid raft association."
FT   MUTAGEN         274
FT                   /note="D->A: Reduced oligomerization and lipid raft
FT                   association."
FT   MUTAGEN         275
FT                   /note="M->A: Reduced oligomerization and lipid raft
FT                   association."
FT   MUTAGEN         276
FT                   /note="L->A: Reduced oligomerization and lipid raft
FT                   association."
FT   CONFLICT        6
FT                   /note="H -> D (in Ref. 3; AAA58432)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        244
FT                   /note="S -> Y (in Ref. 7; AAH10703)"
FT                   /evidence="ECO:0000305"
FT   STRAND          99..109
FT                   /evidence="ECO:0007829|PDB:7WH3"
FT   STRAND          115..127
FT                   /evidence="ECO:0007829|PDB:7WH3"
FT   HELIX           129..134
FT                   /evidence="ECO:0007829|PDB:7WH3"
FT   HELIX           136..156
FT                   /evidence="ECO:0007829|PDB:7WH3"
FT   HELIX           160..163
FT                   /evidence="ECO:0007829|PDB:7WH3"
FT   HELIX           167..183
FT                   /evidence="ECO:0007829|PDB:7WH3"
FT   TURN            184..186
FT                   /evidence="ECO:0007829|PDB:7WH3"
FT   STRAND          187..197
FT                   /evidence="ECO:0007829|PDB:7WH3"
SQ   SEQUENCE   288 AA;  31731 MW;  5FEDA92230D99A24 CRC64;
     MAEKRHTRDS EAQRLPDSFK DSPSKGLGPC GWILVAFSFL FTVITFPISI WMCIKIIKEY
     ERAIIFRLGR ILQGGAKGPG LFFILPCTDS FIKVDMRTIS FDIPPQEILT KDSVTISVDG
     VVYYRVQNAT LAVANITNAD SATRLLAQTT LRNVLGTKNL SQILSDREEI AHNMQSTLDD
     ATDAWGIKVE RVEIKDVKLP VQLQRAMAAE AEASREARAK VIAAEGEMNA SRALKEASMV
     ITESPAALQL RYLQTLTTIA AEKNSTIVFP LPIDMLQGII GAKHSHLG
//
